-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
West Pharmaceutical Services Inc annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- West Pharmaceutical Services Inc Current Income Tax Expense (Benefit) for the quarter ending September 30, 2016 was $700K.
- West Pharmaceutical Services Inc annual Current Income Tax Expense (Benefit) for 2023 was $84.8M, a 41.7% decline from 2022.
- West Pharmaceutical Services Inc annual Current Income Tax Expense (Benefit) for 2022 was $146M, a 3.07% decline from 2021.
- West Pharmaceutical Services Inc annual Current Income Tax Expense (Benefit) for 2021 was $150M, a 91.7% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)